I just saw a tweet about the findings from the Covid-19 Global Rheumatology Alliance. I'll paste part of the 'Key Messages' section here as it explains better than I can:
"Due to underlying immune system dysfunction and the common use of immunosuppressants, there is concern about poorer outcomes in [people with rheumatological diseases] and uncertainty about medication management during the pandemic.
What does this study add?
Moderate to high dose glucocorticoids were associated with a higher risk of hospitalisation for COVID-19.
Biologic therapies, NSAIDs and antimalarial drugs like hydroxychloroquine were not associated with a higher risk of hospitalisation for COVID-19.
How might this impact on clinical practice or future developments?
This study demonstrates that most individuals with rheumatological diseases or on immunosuppressive therapies recover from COVID-19, which should provide some reassurance to patients."
There's a lot more detail in the paper itself which is linked here: ard.bmj.com/content/early/2...
Other key points were that DMARDS alone/+Biologics do not seem to increase risk of hospitalisation, and anti-TNF seems to reduce risk of hospitalisation.
Usual disclaimer - I'm no doctor, and this is obviously only one paper, but it was nice to read something that seems to hold a small amount of good news for a change.